Aberrant activation of the insulin-like growth factor 1 receptor (IGFR1R) has been suggested as one non-genetic cause of third-generation EGFR TKI resistance in T790M mutated NSCLC [72]. Here, EGFR is linked to non-small cell lung carcinoma.